1 not yet recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Not yet recruiting 1 |
Follow BMI>40: new trials by email Literature Review of BMI>40 trials Research Report on BMI>40
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer GLP-1 Receptor Agonist, Levonorgestrel IUD (Lng-IUD), Oral Progestins - Endometrial Cancer, Endometrial Cancer Stage I | Phase 4 | Not yet recruiting | Hospital Universitari de Bellvitge | 80 | 2027-01-01 | 2026-06-10 |
Endometrial Hyperplasia (1) · Endometrial Neoplasms (1) · Neoplasms (1) · Obesity (1) · Overweight (1)
Body Weight (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Neoplasms by Site (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1) · Uterine Diseases (1)
Estrogen Replacement Therapy (1) · Hysterectomy (1) · Hysteroscopy (1) · Magnetic Resonance Spectroscopy (1) · Medroxyprogesterone Acetate (1) · Megestrol Acetate (1) · Nutrition Assessment (1) · Progestins (1) · Resistance Training (1) · semaglutide (1)
Hospital Universitari de Bellvitge (1)
Jorge Garcia Fernandez (1) · Lola Marti (1)